SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending following the submission of an expanded deep-sea mining permit application under NOAA's newly streamlined regulatory process, signaling a significant step towards commercial recovery. This, coupled with an upcoming Congressional hearing featuring TMC's CEO and recent White House support for expediting critical mineral permits, has fueled strong bullish sentiment among investors who see deep-sea resources as a national security priority, with many discussing significant upside potential and a potential short squeeze.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ Corp is trending due to significant strategic announcements, including a new post-quantum semiconductor joint venture in India and a potential acquisition of French quantum computing firm Quobly. The community is actively discussing the company's role in the critical and emerging quantum security sector, with many anticipating a short squeeze driven by high trading volume and a strong belief in the stock's long-term potential following recent positive financial updates and analyst upgrades.

60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by Geoffrey Dow on September 9, 2010 and is headquartered in Washington, DC.

60 Degrees Pharmaceuticals Inc

60 Degrees Pharmaceuticals (SXTP) is experiencing extreme volatility following news of a strategic partnership for malaria prevention and a defined significant market opportunity for its babesiosis treatment. This initial surge was swiftly met with a substantial public offering, leading to a sharp decline and fueling intense community debate over potential dilution versus the long-term value of its product pipeline. Traders are closely watching this low-float biotech as bullish enthusiasm clashes with investor caution regarding the offering's impact.

Creative Media & Community Trust Corp. is a real estate investment trust that seeks to own, operate, and develop premier multifamily and creative office assets in vibrant and emerging communities throughout the United States. It operates through the following segments: Office, Hotel, and Lending. The Office segment consists of the rental of office space and other tenant services, including tenant reimbursements, parking, and storage space rental. The Hotel segment involves the operation of hotel properties. The Lending segment focuses on loans to small businesses. The company was founded in 1993 and is headquartered in Dallas, TX.

Creative Media & Community Trust

Creative Media & Community Trust (CMCT) is generating significant buzz following the announcement of its lending division sale, which yielded substantial net cash proceeds. The community is actively discussing the potential for a parabolic short squeeze, driven by the stock's micro float and comparing its trajectory to other recent volatile movers, despite some mentions of its considerable outstanding debt.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences (GLSI) is generating significant buzz following FDA authorization for the use of its commercially manufactured GP2 drug product in the Phase III FLAMINGO-01 trial, marking a key de-risking milestone for its breast cancer immunotherapy. The community is sharply divided, with bulls pointing to the low float, high short interest, and ongoing insider buying as catalysts for a potential squeeze, while bears highlight a 'sell the news' pattern and anticipate further pullbacks.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending amid community discussions regarding a potential US government agreement concerning Greenland's mineral rights, which many believe directly benefits CRML's Tanbreez rare earth project. Investors are actively discussing the company's strategic importance in establishing a non-China heavy rare earth supply chain, with a recent business update call providing additional insights into project funding and development plans.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending following a significant licensing deal with Pfizer for its Matrix-M adjuvant, validating the technology as a potential "gold standard" in vaccine development. This partnership, alongside existing deals, is fueling strong community speculation about a massive short squeeze given the substantial short interest. Investors are keenly discussing Matrix-M's broad applicability beyond current vaccines and its advantage as a non-aluminum adjuvant, while urging management to capitalize on this momentum.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending due to a recent $150 million registered direct offering, eliciting strong community debate. While some express concern over dilution, many investors see this capital raise as a vital strategic move to fund accelerated production and potential acquisitions for the burgeoning AI data center market. This move is viewed as institutional validation, positioning POET to capitalize on anticipated major orders with its innovative optical interposer technology.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the following segments: Advanced Technology Solutions (ATS), and Connectivity and Cloud Solutions (CCS). The Advanced Technology Solutions (ATS) segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The Connectivity and Cloud Solutions (CCS) segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica is experiencing significant price volatility, fueling intense community debate about the reasons for its recent sharp pullback. Many investors view this as institutional "shake-outs" or short-selling ahead of strong anticipated earnings, leveraging the company's fundamental role in the booming AI infrastructure and high-performance networking sectors. Despite the current market action, the community largely maintains a bullish outlook, expecting continued growth and a sustained rally.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is generating significant conversation, primarily driven by anticipation for early sales data of its newly launched fibromyalgia drug, Tonmya, and recent investor conferences. A substantial investment by Point72 Asset Management has fueled bullish sentiment, with many discussing its potential to trigger a short squeeze, though historical dilution concerns temper some of the optimism.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$KPLT Well after today, no more tax harvesting excuses at least :)
Happy New Year and hope 2026 is a year of less losses and no more execution, cost controls, and leadership failures at KPLT. And hopefully no merging into a pyramid of debt and dilution with a check cashing scheme run by a 20+ year fertilizer CEO with zero experience running a fintech company. Maybe when we see Aaron&#39;s and CCF&#39;s real financials he&#39;s been doing great, but maybe he should have stuck with fertilizer, which he was fired from 🤔 NYE!!

Humphrey Neill

Tinh Nguyen

Mathieu T.

burli buh

StockTwits For Android 

Katapult Holdings Inc

 Well after today, no more tax harvesting excuses at least :)
Happy New Year and hope 2026 is a year of less losses and no more execution, cost controls, and leadership failures at KPLT. And hopefully no merging into a pyramid of debt and dilution with a check cashing scheme run by a 20+ year fertilizer CEO with zero experience running a fintech company. Maybe when we see Aaron's and CCF's real financials he's been doing great, but maybe he should have stuck with fertilizer, which he was fired from 🤔 NYE!!